This combination is indicated to relieve symptoms of dyspepsia, heartburn, acid indigestion, sour stomach, gastroesophageal reflux, and hiatal hernia. It is also prescribed in hyperacidity associated with peptic ulcers, gastritis, and esophagitis. Magalcon may be given to children if necessary. It is also indicated for the relief of flatulence, abdominal distension, and windy colic.

This is a combination of magaldrate and simethicone. Magaldrate (magnesium aluminum compound, i.e., hydroxymagnesium aluminate) neutralizes gastric acid extraordinarily quickly without raising the pH above 5-6. It also decreases the activity of pepsin in gastric secretion. Besides this, simethicone, the other component, enables gas bubbles to coalesce and provides relief from flatulence.

Tablet: 1-4 chewable tablets, 20 to 60 minutes after meals and at bedtime, or as directed by the physician.

Suspension: 2-4 teaspoonfuls (10-20 ml) of suspension, 20 to 60 minutes after meals and at bed time, or as directed by the physician.

Magaldrate is contraindicated in patients with known hypersensitivity to magnesium and aluminum. It is also contraindicated in patients with impaired renal function.

Gastrointestinal side effects are uncommon. Occasionally, if an excessive amount is consumed, diarrhea, constipation, or regurgitation may occur.

Magaldrate may be used in pregnancy if indicated; however, one should avoid excessive dosage. Magaldrate may pass into breast milk but has not been reported to cause problems in nursing babies.

Care should be taken in patients with decreased kidney function, hypophosphatemia, and weak or debilitated individuals.

Overdosage with this formulation is a rare occurrence.

Antacids, Anti-dyspeptic/Carminatives

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.